Business Context and Reporting Period
This Form 6-K filing by Garden Stage Limited covers the month of April 2025, specifically reporting on a corporate financing event dated April 8, 2025. The company is a foreign private issuer headquartered in Hong Kong.
Key Financial Metrics
The filing details a registered direct offering rather than periodic financial performance results.
- Gross Proceeds: Approximately $1.41 million.
- Shares Issued: 4,806,450 ordinary shares.
- Purchase Price: $0.31 per share.
- Use of Proceeds: Working capital and general corporate purposes.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the increase in share capital and cash reserves resulting from the April 8 Registered Direct Offering. The offering closed on April 8, 2025, following the execution of securities purchase agreements on April 7, 2025.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the company's future business, plans, and strategies, including references to previous offerings in December 2024. Management explicitly states that actual results may differ materially from these statements due to inherent uncertainties and risks described in the company's Form 20-F for the year ended December 31, 2023. The company undertakes no obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the final net proceeds after deducting estimated offering expenses.
- Confirm the identity of the "Purchasers" involved in the registered direct offering.
- Review the Form F-3 Registration Statement (File No. 333-283618) for full terms of the securities.
- Assess the impact of the new share issuance on existing shareholder dilution.
- Examine the Form 20-F filed on April 4, 2024, for detailed risk factors referenced in this report.